Today we’re looking at the growing use of continuous glucose monitoring devices – CGMs. Claire Levy talks with Jake Leach, the chief operating officer of CGM developer and manufacturer Dexcom, from their US headquarters in San Diego, California.
This is the first in a short series of interviews about research projects funded by DRWF. In this edition we talk with Dr Stephanie Hanna to discuss her work which identifies the white blood cells that can damage the pancreas in a project aimed at improving the treatment of Type 1 diabetes.
In this edition we hear from Dr. Ana Tiganescu, a university research fellow at Leeds University, about an interesting research project looking at skin healing in diabetes. Although this project isn’t funded by DRWF it does have some interesting findings.
